跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,763 条关于
“Triglyceride-rich lipoproteins”
全部
3,763
临床试验
3,037
药物
58
机构
31
资讯
637
9个月前
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia
去年
Arrowhead Pharmaceuticals Files Patent Lawsuit Against Ionis Over Plozasiran FCS Treatment
上个月
UK Biobank Study Links CKM Syndrome Stages to Stepwise Cancer Risk via Distinct Immune-Metabolic Pathways
9个月前
FDA Approves Plozasiran for Familial Chylomicronemia Syndrome, Marking Breakthrough in Rare Lipid Disorder Treatment
去年
Plozasiran Shows Promise in Phase III Trial for Familial Chylomicronemia Syndrome
去年
Arrowhead Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome
2年前
Arrowhead's Plozasiran Receives FDA Breakthrough Therapy Designation for Familial Chylomicronemia Syndrome
去年
Arrowhead Submits Plozasiran NDA to FDA for Familial Chylomicronemia Syndrome
10个月前
FDA Approves First siRNA Therapy Plozasiran for Rare Metabolic Disorder Familial Chylomicronemia Syndrome
去年
Sanofi Acquires Rights to Plozasiran for $395 Million in Greater China Deal with Arrowhead
第 1 页，共 64 页
上一页
下一页
